Genta, Inc. (GNTA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA)

GNTA 1.770

-2.5%

Dec 9 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Nobrega who started this subject	4/26/2004 2:56:42 AM
From: bob zagorin	of 1870

major story in WSJ monday will feature genansense. should move the stock. here's first graph "...Are Long Trials Always Needed For New Drugs? By ANNA WILDE MATHEWS Staff Reporter of THE WALL STREET JOURNAL April 26, 2004; Page B1 Two years ago, doctors diagnosed David Bernstein with skin cancer and prescribed chemotherapy to remove a grape-size tumor in his chest. Mr. Bernstein opted to supplement the chemotherapy by joining the clinical trial of an experimental drug called Genasense. Six weeks after his first dose, he got remarkable news: The tumor had essentially disappeared. "It worked for me," says Mr. Bernstein, a fourth-grade teacher in Montgomery Township, N.J. "I'm living proof."....." also Aventis news should make this a very interesting day.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next